Tumor-targeting peptide functionalized PEG-PLA micelles for efficient drug delivery

2020 ◽  
Vol 8 (8) ◽  
pp. 2274-2282 ◽  
Author(s):  
Yue Cai ◽  
Zhuomin Xu ◽  
Qi Shuai ◽  
Fangtao Zhu ◽  
Jiao Xu ◽  
...  

PEG-PLA micelles are modified with F3 peptides, thus endowing the micelles with active-targeting ability due to the nucleolin-binding ability of the F3 peptides.

2021 ◽  
Vol 12 ◽  
Author(s):  
Guoliang Liu ◽  
Min Wang ◽  
Hongyu He ◽  
Jiannan Li

Colorectal cancer is the third most common malignant disease worldwide, and chemotherapy has been the standard treatment for colorectal cancer. However, the therapeutic effects of chemotherapy are unsatisfactory for advanced and recurrent colorectal cancers. Thus, increasing the treatment efficacy of chemotherapy in colorectal cancer is a must. In this study, doxorubicin (DOX)-loaded tumor-targeting peptide-decorated mPEG-P(Phe-co-Cys) nanoparticles were developed to treat orthotopic colon cancer in mice. The peptide VATANST (STP) can specifically bind with vimentin highly expressed on the surface of colon cancer cells, thus achieving the tumor-targeting effects. The nanoparticles are core-shell structured, which can protect the loaded DOX while passing through the blood flow and increase the circulation time. The disulfide bonds within the nanoparticles are sensitive to the glutathione-rich microenvironment of tumor tissues. Rupture of disulfide bonds of the nanoparticles leads to the continuous release of DOX, thus resulting in the apoptosis of the tumor cells. The in vivo experiments in mice with orthotopic colon cancer demonstrated that the synthesized DOX-loaded tumor-targeting peptide-decorated polypeptide nanoparticles showed properties of drug delivery systems and exhibited good antitumor properties. The synthesized nanoparticles show appropriate properties as one of the drug delivery systems and exhibit good antitumor properties after encapsulating DOX.


2019 ◽  
Vol 25 (37) ◽  
pp. 3917-3926
Author(s):  
Sajjad Molavipordanjani ◽  
Seyed Jalal Hosseinimehr

Combination of nanotechnology, biochemistry, chemistry and biotechnology provides the opportunity to design unique nanoparticles for tumor targeting, drug delivery, medical imaging and biosensing. Nanoparticles conjugated with biomolecules such as antibodies, peptides, vitamins and aptamer can resolve current challenges including low accumulation, internalization and retention at the target site in cancer diagnosis and therapy through active targeting. In this review, we focus on different strategies for conjugation of biomolecules to nanoparticles such as inorganic nanoparticles (iron oxide, gold, silica and carbon nanoparticles), liposomes, lipid and polymeric nanoparticles and their application in tumor targeting.


2010 ◽  
Vol 72 (2) ◽  
pp. 234-237 ◽  
Author(s):  
Justus Reunanen ◽  
Tanja-Maria Ranta ◽  
Oula Peñate-Medina ◽  
Juho Suojanen ◽  
Timo Sorsa ◽  
...  

2019 ◽  
Vol 53 ◽  
pp. 101144 ◽  
Author(s):  
Simona Giarra ◽  
Noemi Lupo ◽  
Virginia Campani ◽  
Alfonso Carotenuto ◽  
Laura Mayol ◽  
...  

2020 ◽  
Vol 8 (23) ◽  
pp. 6764-6772 ◽  
Author(s):  
Peifei Liu ◽  
Yuanbiao Tu ◽  
Ji Tao ◽  
Zicun Liu ◽  
Fang Wang ◽  
...  

The designed novel targeting peptide GB-6 binding to GRPR possesses more favorable pharmacokinetic properties with lower intestinal activity as well as superior tumor-targeting ability in colorectal cancer models than BBN7–14.


Drug Delivery ◽  
2020 ◽  
Vol 27 (1) ◽  
pp. 1704-1717
Author(s):  
Renna Qiu ◽  
Denghua Sun ◽  
Yuzhuo Bai ◽  
Jiannan Li ◽  
Lizhe Wang

2019 ◽  
Vol 2 (4) ◽  
pp. 1420-1426 ◽  
Author(s):  
Yaxuan Bai ◽  
Zeyu Li ◽  
Liping Liu ◽  
Tiedong Sun ◽  
Xiaocheng Fan ◽  
...  

2010 ◽  
Author(s):  
Hyun-Kyung Jung ◽  
Mi-Kyung Kwak ◽  
Eun-Ju Lee ◽  
Ji Woong Son ◽  
Rang-Woon Park ◽  
...  

2005 ◽  
Vol 24 (5-7) ◽  
pp. 1085-1091 ◽  
Author(s):  
X. Tian ◽  
M. R. Aruva ◽  
H. R. Wolfe ◽  
W. Qin ◽  
E. R. Sauter ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document